Benzinga's Top Initiations

Analysts at Roth Capital initiated coverage on Spark Therapeutics, Inc. ONCE with a Buy rating. The target price for Spark Therapeutics is set to $71. Spark Therapeutics' shares closed at $46.00 yesterday. Analysts at Pacific Crest initiated coverage on Proto Labs, Inc. PRLB with a Sector Perform rating. Proto Labs' shares closed at $71.07 yesterday. Barrington Research initiated coverage on HealthEquity, Inc. HQY with a Outperform rating. The target price for HealthEquity is set to $25. HealthEquity shares closed at $20.13 yesterday. Analysts at Chardan Capital initiated coverage on Avalanche Biotechnologies, Inc. AAVL with a Neutral rating. The target price for Avalanche Biotechnologies is set to $40. Avalanche Biotechnologies' shares closed at $39.74 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsTop Initiations
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!